“I think that DCISionRT has been the single biggest game changer on how we look at DCIS in the last 10 – 20 years.”

“I was an early adopter of DCISionRT and have been recommending it ever since the data was available. I order DCISionRT on every single one of my ductal carcinoma in situ (DCIS) patients. The DCISionRT test can change a lot of the discussions with colleagues and patients, as well as recommended treatments for DCIS.”